Alltrna, a Flagship Pioneering-backed biotech, recently laid off 19 employees. This marks the company's third workforce reduction. The decision aims to prepare Alltrna for clinical trials of its tRNA dr-g candidate. After the layoffs, 36 staffers remain at the Cambridge, Mass.-based company. Alltrna focuses on developing tRNA medicines for genetic liver diseases.
https://www.fiercebiotech.com/biotech/alltrna-undergoes-third-layoff-round-entering-clinic-cutting-35-jobs